WW International, Inc. (WW) Investor Relations Documents

WW International, Inc. (WW) investor relations documents from the company's IR site: 7 presentations, 32 press releases; latest deck 2024-05-02. Read in-app with summaries. First-party data.

Supplemental Investor Materials — WeightWatchers Q1 2024 results report 4.0 million total subscribers and 87,000 clinical subscribers, with a record gross margin of 66.7%.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-05Press releaseNews
2026-08-05Press releasePress Release
2026-07-23Press releaseWeight Watchers Schedules Second Quarter 2026 Earnings Conference Call
2026-07-08Press releaseWeight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community
2026-06-30Press releaseWeight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program
2026-06-22Press releaseWeight Watchers to Support the American Heart Association’s Healthy Living BEYOND Weight Study
2026-06-16Press releaseWeight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK
2026-06-04Press releaseWeight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect
2026-05-01Press releaseWeight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)
2026-04-27Press releaseWeight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
2026-04-23Press releaseWeight Watchers Schedules First Quarter 2026 Earnings Conference Call
2026-04-20Press releaseWeight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
2026-04-09Press releaseWeight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect
2026-04-09Press releaseWeight Watchers Announces Board Committee Appointments
2026-04-07Press releaseWeight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
2026-04-03Press releaseWeight Watchers Announces Leadership Transition and Board Updates
2026-03-31Press releaseWeight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscript
2026-03-11Press releaseWeight Watchers Report Finds Integrated GLP-1 Support Drives Significantly Greater Weight Loss Than Medication Alone
2026-02-27Press releaseWeight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
2026-02-10Press releaseWeight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era
2026-01-07Press releaseWeight Watchers to Participate in Upcoming Investor Conferences
2026-01-05Press releaseWeight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term
2024-11-06Quarterly reportQ3 2024 Earnings Conference Call
2024-11-06Press releaseQ3
2024-08-01Press releaseQ2
2024-05-02PresentationSupplemental Investor Materials
2024-05-02Press releaseQ1
2024-02-28PresentationSupplemental Investor Materials
2024-02-28Press releaseQ4
2023-11-02PresentationSupplemental Investor Materials
2023-11-02Press releaseQ3
2023-08-03PresentationSupplemental Investor Materials
2023-08-03Press releaseQ2
2023-05-04Press releaseQ1
2023-03-06PresentationSupplemental Investor Materials
2023-03-06Press releaseQ4
2022-11-03PresentationSupplemental Investor Materials
2022-11-03Press releaseQ3
2022-08-04PresentationSupplemental Investor Materials
2022-08-04Press releaseQ2

WW overview · WW earnings · WW financials · WW KPIs · WW ownership · WW peers · WW filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.